TreeWAS – Variant ID: rs151361

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
L30.9 Dermatitis, unspecified	0.000	0.887	0.113
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.060	0.940	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.053	0.947	0.000
T39.0 Salicylates	0.044	0.956	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.043	0.957	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.041	0.959	0.000
T39.1 4-Aminophenol derivatives	0.040	0.960	0.000
T39.4 Antirheumatics, not elsewhere classified	0.038	0.962	0.000
T39.2 Pyrazolone derivatives	0.038	0.962	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.035	0.965	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.034	0.966	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.034	0.966	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.033	0.967	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.033	0.967	0.000
T36 Poisoning by systemic antibiotics	0.033	0.967	0.000
L30 Other dermatitis	0.000	0.968	0.032
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.032	0.968	0.000
T45.5 Anticoagulants	0.031	0.969	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.031	0.969	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.030	0.969	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.030	0.970	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.030	0.970	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.029	0.971	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.029	0.971	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.029	0.971	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.029	0.971	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.028	0.972	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.028	0.972	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.028	0.972	0.000
T42.1 Iminostilbenes	0.028	0.972	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.028	0.972	0.000
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.027	0.973	0.000
T36.4 Tetracyclines	0.027	0.973	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.027	0.973	0.000
T47.6 Antidiarrhoeal drugs	0.027	0.973	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.027	0.973	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.027	0.973	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.027	0.973	0.000
T47.0 Histamine H(2)-receptor antagonists	0.026	0.973	0.000
T40.4 Other synthetic narcotics	0.026	0.974	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.025	0.975	0.000
T45.8 Other primarily systemic and haematological agents	0.025	0.975	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.025	0.975	0.000
T45.6 Fibrinolysis-affecting drugs	0.025	0.975	0.000
T45.4 Iron and its compounds	0.025	0.975	0.000
T45.3 Enzymes, not elsewhere classified	0.025	0.975	0.000
T42.0 Hydantoin derivatives	0.025	0.975	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.025	0.975	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.025	0.975	0.000
T47.7 Emetics	0.025	0.975	0.000
T47.5 Digestants	0.025	0.975	0.000
T47.4 Other laxatives	0.025	0.975	0.000
T47.3 Saline and osmotic laxatives	0.025	0.975	0.000
T47.2 Stimulant laxatives	0.025	0.975	0.000
T45.2 Vitamins, not elsewhere classified	0.025	0.975	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.024	0.975	0.000
T37.5 Antiviral drugs	0.024	0.975	0.000
T37.4 Anthelminthics	0.024	0.975	0.000
T37.3 Other antiprotozoal drugs	0.024	0.975	0.000
T37.1 Antimycobacterial drugs	0.024	0.975	0.000
T37.0 Sulphonamides	0.024	0.975	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.024	0.976	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.024	0.976	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.024	0.976	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.024	0.976	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.024	0.976	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.024	0.976	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.024	0.976	0.000
T44.0 Anticholinesterase agents	0.024	0.976	0.000
T50.4 Drugs affecting uric acid metabolism	0.024	0.976	0.000
G31.8 Other specified degenerative diseases of nervous system	0.024	0.976	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.024	0.976	0.000
T42.3 Barbiturates	0.024	0.976	0.000
T42.2 Succinimides and oxazolidinediones	0.024	0.976	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.024	0.976	0.000
T36.9 Systemic antibiotic, unspecified	0.024	0.976	0.000
T36.8 Other systemic antibiotics	0.024	0.976	0.000
T36.7 Antifungal antibiotics, systemically used	0.024	0.976	0.000
T36.6 Rifamycins	0.024	0.976	0.000
T36.5 Aminoglycosides	0.024	0.976	0.000
T36.3 Macrolides	0.024	0.976	0.000
T36.2 Chloramphenicol group	0.024	0.976	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.024	0.976	0.000
T36.0 Penicillins	0.024	0.976	0.000
G31.2 Degeneration of nervous system due to alcohol	0.023	0.976	0.000
L30.5 Pityriasis alba	0.000	0.977	0.023
L30.4 Erythema intertrigo	0.000	0.977	0.023
L30.3 Infective dermatitis	0.000	0.977	0.023
L30.2 Cutaneous autosensitisation	0.000	0.977	0.023
L30.0 Nummular dermatitis	0.000	0.977	0.023
T48.6 Antiasthmatics, not elsewhere classified	0.023	0.977	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.023	0.977	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.022	0.978	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.022	0.978	0.000
T48.5 Anti-common-cold drugs	0.022	0.978	0.000
T48.4 Expectorants	0.022	0.978	0.000
T48.3 Antitussives	0.022	0.978	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.022	0.978	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.022	0.978	0.000
T48.0 Oxytocic drugs	0.022	0.978	0.000
G31.0 Circumscribed brain atrophy	0.022	0.978	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.022	0.978	0.000
T41.5 Therapeutic gases	0.021	0.978	0.000
T41.4 Anaesthetic, unspecified	0.021	0.978	0.000
T41.3 Local anaesthetics	0.021	0.978	0.000
T41.2 Other and unspecified general anaesthetics	0.021	0.978	0.000
T41.1 Intravenous anaesthetics	0.021	0.978	0.000
T41.0 Inhaled anaesthetics	0.021	0.978	0.000
T49.9 Topical agent, unspecified	0.021	0.978	0.000
T49.8 Other topical agents	0.021	0.978	0.000
T49.7 Dental drugs, topically applied	0.021	0.978	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.021	0.978	0.000
T49.5 Ophthalmological drugs and preparations	0.021	0.978	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.021	0.978	0.000
T49.3 Emollients, demulcents and protectants	0.021	0.978	0.000
T49.2 Local astringents and local detergents	0.021	0.978	0.000
T49.1 Antipruritics	0.021	0.978	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.021	0.978	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.021	0.979	0.000
T40.8 Lysergide [LSD]	0.021	0.979	0.000
T40.7 Cannabis (derivatives)	0.021	0.979	0.000
T40.5 Cocaine	0.021	0.979	0.000
T40.3 Methadone	0.021	0.979	0.000
T40.1 Heroin	0.021	0.979	0.000
T40.0 Opium	0.021	0.979	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.021	0.979	0.000
T38.9 Other and unspecified hormone antagonists	0.021	0.979	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.021	0.979	0.000
T38.7 Androgens and anabolic congeners	0.021	0.979	0.000
T38.5 Other oestrogens and progestogens	0.021	0.979	0.000
T38.4 Oral contraceptives	0.021	0.979	0.000
T38.2 Antithyroid drugs	0.021	0.979	0.000
T38.1 Thyroid hormones and substitutes	0.021	0.979	0.000
T38.0 Glucocorticoids and synthetic analogues	0.021	0.979	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.021	0.979	0.000
T40.6 Other and unspecified narcotics	0.020	0.979	0.000
T50.8 Diagnostic agents	0.020	0.980	0.000
T50.7 Analeptics and opioid receptor antagonists	0.020	0.980	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.020	0.980	0.000
T50.5 Appetite depressants	0.020	0.980	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.020	0.980	0.000
T50.1 Loop [high-ceiling] diuretics	0.020	0.980	0.000
T50.0 Mineralocorticoids and their antagonists	0.020	0.980	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.020	0.980	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.020	0.980	0.000
T46.7 Peripheral vasodilators	0.020	0.980	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.020	0.980	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.020	0.980	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.020	0.980	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.020	0.980	0.000
L30.8 Other specified dermatitis	0.000	0.980	0.020
M47.92 Spondylosis, unspecified (Cervical region)	0.020	0.980	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.019	0.981	0.000
L30.1 Dyshidrosis [pompholyx]	0.000	0.981	0.019
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.019	0.981	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.019	0.981	0.000
T45.0 Antiallergic and antiemetic drugs	0.018	0.981	0.000
T46.1 Calcium-channel blockers	0.018	0.982	0.000
R50.0 Fever with chills	0.018	0.982	0.000
M47 Spondylosis	0.017	0.983	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.017	0.983	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.017	0.983	0.000
M47.1 Other spondylosis with myelopathy	0.017	0.983	0.000
M47.2 Other spondylosis with radiculopathy	0.017	0.983	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.017	0.983	0.000
M47.9 Spondylosis, unspecified	0.017	0.983	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.016	0.984	0.000
F17.2 Dependence syndrome	0.016	0.984	0.000
T43.9 Psychotropic drug, unspecified	0.015	0.985	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.015	0.985	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.015	0.985	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.015	0.985	0.000
M47.8 Other spondylosis	0.015	0.985	0.000
T43.2 Other and unspecified antidepressants	0.015	0.985	0.000
M47.88 Other spondylosis (Sacral and sacrococcygeal region)	0.014	0.986	0.000
M47.80 Other spondylosis (Multiple sites in spine)	0.013	0.987	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
M47.89 Other spondylosis (Site unspecified)	0.013	0.987	0.000
M47.0 Anterior spinal and vertebral artery compression syndromes	0.013	0.987	0.000
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.013	0.987	0.000
M47.16 Other spondylosis with myelopathy (Lumbar region)	0.013	0.987	0.000
M47.19 Other spondylosis with myelopathy (Site unspecified)	0.012	0.987	0.000
M47.18 Other spondylosis with myelopathy (Sacral and sacrococcygeal region)	0.012	0.987	0.000
M47.17 Other spondylosis with myelopathy (Lumbosacral region)	0.012	0.987	0.000
M47.15 Other spondylosis with myelopathy (Thoracolumbar region)	0.012	0.987	0.000
M47.14 Other spondylosis with myelopathy (Thoracic region)	0.012	0.987	0.000
M47.13 Other spondylosis with myelopathy (Cervicothoracic region)	0.012	0.987	0.000
M47.11 Other spondylosis with myelopathy (Occipito-atlanto-axial region)	0.012	0.987	0.000
M47.10 Other spondylosis with myelopathy (Multiple sites in spine)	0.012	0.987	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.012	0.988	0.000
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.012	0.988	0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.012	0.988	0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.012	0.988	0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.012	0.988	0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.012	0.988	0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.012	0.988	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.012	0.988	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.012	0.988	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.012	0.988	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.012	0.988	0.000
T43.6 Psychostimulants with abuse potential	0.012	0.988	0.000
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.012	0.988	0.000
J18.9 Pneumonia, unspecified	0.012	0.988	0.000
F02.3 Dementia in Parkinson's disease	0.012	0.988	0.000
G30-G32 Other degenerative diseases of the nervous system	0.012	0.988	0.000
F02 Dementia in other diseases classified elsewhere	0.011	0.989	0.000
M47.84 Other spondylosis (Thoracic region)	0.011	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.011	0.989	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.011	0.989	0.000
M47.83 Other spondylosis (Cervicothoracic region)	0.011	0.989	0.000
M47.81 Other spondylosis (Occipito-atlanto-axial region)	0.011	0.989	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.011	0.989	0.000
F02.0 Dementia in Pick's disease	0.011	0.989	0.000
M47.85 Other spondylosis (Thoracolumbar region)	0.010	0.990	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.010	0.990	0.000
F17 Mental and behavioural disorders due to use of tobacco	0.010	0.990	0.000
M47.09 Anterior spinal and vertebral artery compression syndromes (Site unspecified)	0.009	0.991	0.000
M47.08 Anterior spinal and vertebral artery compression syndromes (Sacral and sacrococcygeal region)	0.009	0.991	0.000
M47.07 Anterior spinal and vertebral artery compression syndromes (Lumbosacral region)	0.009	0.991	0.000
M47.06 Anterior spinal and vertebral artery compression syndromes (Lumbar region)	0.009	0.991	0.000
M47.05 Anterior spinal and vertebral artery compression syndromes (Thoracolumbar region)	0.009	0.991	0.000
M47.04 Anterior spinal and vertebral artery compression syndromes (Thoracic region)	0.009	0.991	0.000
M47.03 Anterior spinal and vertebral artery compression syndromes (Cervicothoracic region)	0.009	0.991	0.000
M47.02 Anterior spinal and vertebral artery compression syndromes (Cervical region)	0.009	0.991	0.000
M47.01 Anterior spinal and vertebral artery compression syndromes (Occipito-atlanto-axial region)	0.009	0.991	0.000
M47.00 Anterior spinal and vertebral artery compression syndromes (Multiple sites in spine)	0.009	0.991	0.000
J18 Pneumonia, organism unspecified	0.009	0.991	0.000
M47.86 Other spondylosis (Lumbar region)	0.009	0.991	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.009	0.991	0.000
F12.1 Harmful use	0.009	0.991	0.000
J14 Pneumonia due to Haemophilus influenzae	0.009	0.991	0.000
J09-J18 Influenza and pneumonia	0.009	0.991	0.000
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.009	0.991	0.000
J11 Influenza, virus not identified	0.009	0.991	0.000
J18.0 Bronchopneumonia, unspecified	0.009	0.991	0.000
F12 Mental and behavioural disorders due to use of cannabinoids	0.009	0.991	0.000
J15 Bacterial pneumonia, not elsewhere classified	0.009	0.991	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.008	0.991	0.000
F02.2 Dementia in Huntington's disease	0.008	0.991	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.008	0.991	0.000
J11.1 Influenza with other respiratory manifestations, virus not identified	0.008	0.991	0.000
J15.0 Pneumonia due to Klebsiella pneumoniae	0.008	0.992	0.000
F10-F19 Mental and behavioural disorders due to psychoactive substance use	0.008	0.992	0.000
T42.4 Benzodiazepines	0.008	0.992	0.000
D12.2 Ascending colon	0.000	0.992	0.008
G30 Alzheimer's disease	0.008	0.992	0.000
I99 Other and unspecified disorders of circulatory system	0.008	0.992	0.000
F17.9 Unspecified mental and behavioural disorder	0.007	0.993	0.000
F17.8 Other mental and behavioural disorders	0.007	0.993	0.000
F17.7 Residual and late-onset psychotic disorder	0.007	0.993	0.000
F17.6 Amnesic syndrome	0.007	0.993	0.000
F17.5 Psychotic disorder	0.007	0.993	0.000
F17.4 Withdrawal state with delirium	0.007	0.993	0.000
F17.3 Withdrawal state	0.007	0.993	0.000
F17.0 Acute intoxication	0.007	0.993	0.000
J15.9 Bacterial pneumonia, unspecified	0.007	0.993	0.000
J15.4 Pneumonia due to other streptococci	0.007	0.993	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
R50 Fever of unknown origin	0.007	0.993	0.000
J10 Influenza due to identified influenza virus	0.007	0.993	0.000
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.007	0.993	0.000
J18.2 Hypostatic pneumonia, unspecified	0.007	0.993	0.000
J12 Viral pneumonia, not elsewhere classified	0.007	0.993	0.000
J11.0 Influenza with pneumonia, virus not identified	0.007	0.993	0.000
F12.2 Dependence syndrome	0.007	0.993	0.000
J15.8 Other bacterial pneumonia	0.007	0.993	0.000
R50.8 Other specified fever	0.007	0.993	0.000
J16 Pneumonia due to other infectious organisms, not elsewhere classified	0.007	0.993	0.000
J09 Influenza due to certain identified influenza virus	0.007	0.993	0.000
G90.2 Horner's syndrome	0.007	0.993	0.000
J15.6 Pneumonia due to other aerobic Gram-negative bacteria	0.007	0.993	0.000
J15.7 Pneumonia due to Mycoplasma pneumoniae	0.007	0.993	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.007	0.993	0.000
G90 Disorders of autonomic nervous system	0.007	0.993	0.000
J11.8 Influenza with other manifestations, virus not identified	0.006	0.993	0.000
N36.2 Urethral caruncle	0.007	0.993	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.007	0.993	0.000
G30.9 Alzheimer's disease, unspecified	0.006	0.994	0.000
F12.9 Unspecified mental and behavioural disorder	0.006	0.994	0.000
F12.8 Other mental and behavioural disorders	0.006	0.994	0.000
F12.7 Residual and late-onset psychotic disorder	0.006	0.994	0.000
F12.6 Amnesic syndrome	0.006	0.994	0.000
F12.5 Psychotic disorder	0.006	0.994	0.000
F12.4 Withdrawal state with delirium	0.006	0.994	0.000
F12.3 Withdrawal state	0.006	0.994	0.000
F12.0 Acute intoxication	0.006	0.994	0.000
J15.3 Pneumonia due to streptococcus, group B	0.006	0.994	0.000
J15.5 Pneumonia due to Escherichia coli	0.006	0.994	0.000
G90.0 Idiopathic peripheral autonomic neuropathy	0.006	0.994	0.000
F15 Mental and behavioural disorders due to use of other stimulants, including caffeine	0.006	0.994	0.000
S30 Superficial injury of abdomen, lower back and pelvis	0.006	0.994	0.000
G90.3 Multisystem degeneration	0.006	0.994	0.000
J17 Pneumonia in diseases classified elsewhere	0.006	0.994	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.006	0.994	0.000
F18 Mental and behavioural disorders due to use of volatile solvents	0.006	0.994	0.000
F16 Mental and behavioural disorders due to use of hallucinogens	0.006	0.994	0.000
F14 Mental and behavioural disorders due to use of cocaine	0.006	0.994	0.000
G30.1 Alzheimer's disease with late onset	0.006	0.994	0.000
G55.2 Nerve root and plexus compressions in spondylosis	0.006	0.994	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.006	0.994	0.000
F13 Mental and behavioural disorders due to use of sedatives or hypnotics	0.006	0.994	0.000
E61.1 Iron deficiency	0.006	0.994	0.000
J12.1 Respiratory syncytial virus pneumonia	0.005	0.994	0.000
G90.9 Disorder of autonomic nervous system, unspecified	0.006	0.994	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.005	0.994	0.000
R50.1 Persistent fever	0.005	0.995	0.000
T83.8 Other complications of genito-urinary prosthetic devices, implants and grafts	0.005	0.995	0.000
F11 Mental and behavioural disorders due to use of opioids	0.005	0.995	0.000
J10.0 Influenza with pneumonia, influenza virus identified	0.005	0.995	0.000
J10.8 Influenza with other manifestations, influenza virus identified	0.005	0.995	0.000
R50.2 Drug-induced fever	0.005	0.995	0.000
G30.8 Other Alzheimer's disease	0.005	0.995	0.000
Chapter V Mental and behavioural disorders	0.005	0.995	0.000
C78.0 Secondary malignant neoplasm of lung	0.000	0.995	0.005
J12.8 Other viral pneumonia	0.005	0.995	0.000
J12.3 Human metapneumovirus pneumonia	0.005	0.995	0.000
J12.2 Parainfluenza virus pneumonia	0.005	0.995	0.000
J12.0 Adenoviral pneumonia	0.005	0.995	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.005	0.995	0.000
J16.8 Pneumonia due to other specified infectious organisms	0.005	0.995	0.000
J16.0 Chlamydial pneumonia	0.005	0.995	0.000
J18.8 Other pneumonia, organism unspecified	0.005	0.995	0.000
J12.9 Viral pneumonia, unspecified	0.005	0.995	0.000
J15.1 Pneumonia due to Pseudomonas	0.005	0.995	0.000
F06.7 Mild cognitive disorder	0.005	0.995	0.000
G90.8 Other disorders of autonomic nervous system	0.005	0.995	0.000
G90.4 Autonomic dysreflexia	0.005	0.995	0.000
G90.1 Familial dysautonomia [Riley-Day]	0.005	0.995	0.000
F15.1 Harmful use	0.005	0.995	0.000
F09 Unspecified organic or symptomatic mental disorder	0.005	0.995	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.005	0.995	0.000
F19.1 Harmful use	0.005	0.995	0.000
G30.0 Alzheimer's disease with early onset	0.005	0.995	0.000
J17.3 Pneumonia in parasitic diseases	0.005	0.995	0.000
C78.2 Secondary malignant neoplasm of pleura	0.000	0.995	0.005
F15.9 Unspecified mental and behavioural disorder	0.005	0.995	0.000
F15.8 Other mental and behavioural disorders	0.005	0.995	0.000
F15.7 Residual and late-onset psychotic disorder	0.005	0.995	0.000
F15.6 Amnesic syndrome	0.005	0.995	0.000
F15.5 Psychotic disorder	0.005	0.995	0.000
F15.4 Withdrawal state with delirium	0.005	0.995	0.000
F15.3 Withdrawal state	0.005	0.995	0.000
F15.2 Dependence syndrome	0.005	0.995	0.000
F15.0 Acute intoxication	0.005	0.995	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.005	0.995	0.000
J17.8 Pneumonia in other diseases classified elsewhere	0.004	0.995	0.000
J17.1 Pneumonia in viral diseases classified elsewhere	0.004	0.995	0.000
F99-F99 Unspecified mental disorder	0.005	0.995	0.000
F17.1 Harmful use	0.005	0.995	0.000
F19.9 Unspecified mental and behavioural disorder	0.004	0.995	0.000
F19.8 Other mental and behavioural disorders	0.004	0.995	0.000
F19.7 Residual and late-onset psychotic disorder	0.004	0.995	0.000
F19.6 Amnesic syndrome	0.004	0.995	0.000
F19.5 Psychotic disorder	0.004	0.995	0.000
F19.4 Withdrawal state with delirium	0.004	0.995	0.000
F19.3 Withdrawal state	0.004	0.995	0.000
F19.0 Acute intoxication	0.004	0.995	0.000
F14.9 Unspecified mental and behavioural disorder	0.004	0.995	0.000
F14.8 Other mental and behavioural disorders	0.004	0.995	0.000
F14.7 Residual and late-onset psychotic disorder	0.004	0.995	0.000
F14.6 Amnesic syndrome	0.004	0.995	0.000
F14.5 Psychotic disorder	0.004	0.995	0.000
F14.4 Withdrawal state with delirium	0.004	0.995	0.000
F14.3 Withdrawal state	0.004	0.995	0.000
F14.2 Dependence syndrome	0.004	0.995	0.000
F14.1 Harmful use	0.004	0.995	0.000
F14.0 Acute intoxication	0.004	0.995	0.000
F16.9 Unspecified mental and behavioural disorder	0.004	0.995	0.000
F16.8 Other mental and behavioural disorders	0.004	0.995	0.000
F16.7 Residual and late-onset psychotic disorder	0.004	0.995	0.000
F16.6 Amnesic syndrome	0.004	0.995	0.000
F16.5 Psychotic disorder	0.004	0.995	0.000
F16.4 Withdrawal state with delirium	0.004	0.995	0.000
F16.3 Withdrawal state	0.004	0.995	0.000
F16.2 Dependence syndrome	0.004	0.995	0.000
F16.1 Harmful use	0.004	0.995	0.000
F16.0 Acute intoxication	0.004	0.995	0.000
F18.9 Unspecified mental and behavioural disorder	0.004	0.995	0.000
F18.8 Other mental and behavioural disorders	0.004	0.995	0.000
F18.7 Residual and late-onset psychotic disorder	0.004	0.995	0.000
F18.6 Amnesic syndrome	0.004	0.995	0.000
F18.5 Psychotic disorder	0.004	0.995	0.000
F18.4 Withdrawal state with delirium	0.004	0.995	0.000
F18.3 Withdrawal state	0.004	0.995	0.000
F18.2 Dependence syndrome	0.004	0.995	0.000
F18.1 Harmful use	0.004	0.995	0.000
F18.0 Acute intoxication	0.004	0.995	0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.995	0.005
J13 Pneumonia due to Streptococcus pneumoniae	0.004	0.995	0.000
F01 Vascular dementia	0.004	0.995	0.000
F00 Dementia in Alzheimer's disease	0.004	0.995	0.000
F50-F59 Behavioural syndromes associated with physiological disturbances and physical factors	0.004	0.996	0.000
F50.0 Anorexia nervosa	0.004	0.996	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.000	0.996	0.004
F60-F69 Disorders of adult personality and behaviour	0.004	0.996	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.004	0.996	0.000
M47.87 Other spondylosis (Lumbosacral region)	0.004	0.996	0.000
F50 Eating disorders	0.004	0.996	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.004	0.996	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.004	0.996	0.000
F06.5 Organic dissociative disorder	0.004	0.996	0.000
F06.4 Organic anxiety disorder	0.004	0.996	0.000
F06.3 Organic mood [affective] disorders	0.004	0.996	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.004	0.996	0.000
F06.1 Organic catatonic disorder	0.004	0.996	0.000
F06.0 Organic hallucinosis	0.004	0.996	0.000
F13.9 Unspecified mental and behavioural disorder	0.004	0.996	0.000
F13.8 Other mental and behavioural disorders	0.004	0.996	0.000
F13.7 Residual and late-onset psychotic disorder	0.004	0.996	0.000
F13.6 Amnesic syndrome	0.004	0.996	0.000
F13.5 Psychotic disorder	0.004	0.996	0.000
F13.4 Withdrawal state with delirium	0.004	0.996	0.000
F13.3 Withdrawal state	0.004	0.996	0.000
F13.1 Harmful use	0.004	0.996	0.000
F13.0 Acute intoxication	0.004	0.996	0.000
F19.2 Dependence syndrome	0.004	0.996	0.000
S30.1 Contusion of abdominal wall	0.004	0.996	0.000
F90-F98 Behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.004	0.996	0.000
D28.0 Vulva	0.000	0.996	0.004
J17.0 Pneumonia in bacterial diseases classified elsewhere	0.004	0.996	0.000
J15.2 Pneumonia due to staphylococcus	0.004	0.996	0.000
F07.0 Organic personality disorder	0.004	0.996	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.000	0.996	0.004
F70-F79 Mental retardation	0.004	0.996	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.004	0.996	0.000
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.004	0.996	0.000
F99 Mental disorder, not otherwise specified	0.004	0.996	0.000
F11.9 Unspecified mental and behavioural disorder	0.004	0.996	0.000
F11.8 Other mental and behavioural disorders	0.004	0.996	0.000
F11.7 Residual and late-onset psychotic disorder	0.004	0.996	0.000
F11.6 Amnesic syndrome	0.004	0.996	0.000
F11.5 Psychotic disorder	0.004	0.996	0.000
F11.4 Withdrawal state with delirium	0.004	0.996	0.000
F11.3 Withdrawal state	0.004	0.996	0.000
F11.0 Acute intoxication	0.004	0.996	0.000
F03 Unspecified dementia	0.004	0.996	0.000
J17.2 Pneumonia in mycoses	0.004	0.996	0.000
F11.1 Harmful use	0.004	0.996	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.004	0.996	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.004	0.996	0.000
F07.1 Postencephalitic syndrome	0.004	0.996	0.000
K63.3 Ulcer of intestine	0.000	0.996	0.004
G55 Nerve root and plexus compressions in diseases classified elsewhere	0.004	0.996	0.000
F13.2 Dependence syndrome	0.004	0.996	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.996	0.004
F07.2 Postconcussional syndrome	0.004	0.996	0.000
S30.2 Contusion of external genital organs	0.004	0.996	0.000
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.000	0.996	0.004
F60 Specific personality disorders	0.004	0.996	0.000
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.996	0.004
G55.0 Nerve root and plexus compressions in neoplastic disease	0.004	0.996	0.000
F00.0 Dementia in Alzheimer's disease with early onset	0.004	0.996	0.000
F11.2 Dependence syndrome	0.003	0.996	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.000	0.996	0.004
F50.9 Eating disorder, unspecified	0.003	0.996	0.000
F90 Hyperkinetic disorders	0.003	0.996	0.000
L20-L30 Dermatitis and eczema	0.000	0.996	0.004
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.000	0.996	0.003
F00.1 Dementia in Alzheimer's disease with late onset	0.003	0.996	0.000
F01.8 Other vascular dementia	0.003	0.996	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.003	0.996	0.000
F01.2 Subcortical vascular dementia	0.003	0.996	0.000
F01.1 Multi-infarct dementia	0.003	0.996	0.000
F01.0 Vascular dementia of acute onset	0.003	0.996	0.000
M96.0 Pseudarthrosis after fusion or arthrodesis	0.003	0.996	0.000
F53 Mental and behavioural disorders associated with the puerperium, not elsewhere classified	0.003	0.997	0.000
F59 Unspecified behavioural syndromes associated with physiological disturbances and physical factors	0.003	0.997	0.000
F55 Abuse of non-dependence-producing substances	0.003	0.997	0.000
F54 Psychological and behavioural factors associated with disorders or diseases classified elsewhere	0.003	0.997	0.000
F51 Nonorganic sleep disorders	0.003	0.997	0.000
F68 Other disorders of adult personality and behaviour	0.003	0.997	0.000
F66 Psychological and behavioural disorders associated with sexual development and orientation	0.003	0.997	0.000
F65 Disorders of sexual preference	0.003	0.997	0.000
F63 Habit and impulse disorders	0.003	0.997	0.000
F62 Enduring personality changes, not attributable to brain damage and disease	0.003	0.997	0.000
F61 Mixed and other personality disorders	0.003	0.997	0.000
F79 Unspecified mental retardation	0.003	0.997	0.000
H81.1 Benign paroxysmal vertigo	0.003	0.997	0.000
F50.8 Other eating disorders	0.003	0.997	0.000
F50.5 Vomiting associated with other psychological disturbances	0.003	0.997	0.000
F50.4 Overeating associated with other psychological disturbances	0.003	0.997	0.000
F50.3 Atypical bulimia nervosa	0.003	0.997	0.000
F50.1 Atypical anorexia nervosa	0.003	0.997	0.000
F43.1 Posttraumatic stress disorder	0.003	0.997	0.000
F98 Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence	0.003	0.997	0.000
F95 Tic disorders	0.003	0.997	0.000
F94 Disorders of social functioning with onset specific to childhood and adolescence	0.003	0.997	0.000
F93 Emotional disorders with onset specific to childhood	0.003	0.997	0.000
F92 Mixed disorders of conduct and emotions	0.003	0.997	0.000
F91 Conduct disorders	0.003	0.997	0.000
F43.0 Acute stress reaction	0.003	0.997	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.003	0.997	0.000
G93.9 Disorder of brain, unspecified	0.003	0.997	0.000
J30.3 Other allergic rhinitis	0.003	0.997	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.000	0.997	0.003
F45 Somatoform disorders	0.003	0.997	0.000
F64 Gender identity disorders	0.003	0.997	0.000
F78 Other mental retardation	0.003	0.997	0.000
F73 Profound mental retardation	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations